Mendelian randomisation study of the effects of known and putative risk factors on pancreatic cancer.
Ye LuManuel GentiluomoJusto Lorenzo-BermejoLuca MorelliOfure ObazeeDaniele CampaFederico CanzianPublished in: Journal of medical genetics (2020)
We found strong evidence that BMI is causally associated with PDAC risk, providing support that obesity management may be a potential prevention strategy for reducing pancreatic cancer risk while fasting insulin and type 2 diabetes showed a suggestive association that should be further investigated.